{"id":789495,"date":"2025-05-20T12:34:51","date_gmt":"2025-05-20T09:34:51","guid":{"rendered":""},"modified":"2025-05-20T14:31:30","modified_gmt":"2025-05-20T11:31:30","slug":"vitayemo-z-mizhnarodnym-dnem-klinichnyh-doslidzhen-2","status":"publish","type":"post","link":"https:\/\/new.eba.com.ua\/en\/vitayemo-z-mizhnarodnym-dnem-klinichnyh-doslidzhen-2\/","title":{"rendered":"International Clinical Trials Day"},"content":{"rendered":"<p class=\"x_MsoNormal\">For over three years, the clinical trials industry in Ukraine has been operating under extremely challenging conditions due to russia\u2019s full-scale war against Ukraine. Yet the resilience, professionalism, and dignity shown by everyone involved in this field are inspiring.<\/p>\n<p class=\"x_MsoNormal\">Sponsors, contract research organizations, logistics providers \u2014 despite all existing threats \u2014 remain loyal to patients and to science. They continue running studies, supporting their teams, preserving jobs, investing in the country, and paying taxes. Investigators and doctors maintain the high quality of clinical trials, pursue professional development, and implement new knowledge, medical technologies, and innovations. And patients \u2014 despite all the challenges \u2014 do not lose hope, strength, or their desire to live.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-643800 size-full\" src=\"https:\/\/new.eba.com.ua\/wp-content\/uploads\/2025\/05\/Den_KD_2025_one_page_ENG.png\" alt=\"\" width=\"1920\" height=\"1080\" srcset=\"https:\/\/new.eba.com.ua\/wp-content\/uploads\/2025\/05\/Den_KD_2025_one_page_ENG.png 1920w, https:\/\/new.eba.com.ua\/wp-content\/uploads\/2025\/05\/Den_KD_2025_one_page_ENG-300x169.png 300w, https:\/\/new.eba.com.ua\/wp-content\/uploads\/2025\/05\/Den_KD_2025_one_page_ENG-1024x576.png 1024w, https:\/\/new.eba.com.ua\/wp-content\/uploads\/2025\/05\/Den_KD_2025_one_page_ENG-768x432.png 768w, https:\/\/new.eba.com.ua\/wp-content\/uploads\/2025\/05\/Den_KD_2025_one_page_ENG-1536x864.png 1536w, https:\/\/new.eba.com.ua\/wp-content\/uploads\/2025\/05\/Den_KD_2025_one_page_ENG-650x366.png 650w, https:\/\/new.eba.com.ua\/wp-content\/uploads\/2025\/05\/Den_KD_2025_one_page_ENG-570x320.png 570w, https:\/\/new.eba.com.ua\/wp-content\/uploads\/2025\/05\/Den_KD_2025_one_page_ENG-270x152.png 270w, https:\/\/new.eba.com.ua\/wp-content\/uploads\/2025\/05\/Den_KD_2025_one_page_ENG-800x450.png 800w, https:\/\/new.eba.com.ua\/wp-content\/uploads\/2025\/05\/Den_KD_2025_one_page_ENG-125x70.png 125w, https:\/\/new.eba.com.ua\/wp-content\/uploads\/2025\/05\/Den_KD_2025_one_page_ENG-100x56.png 100w\" sizes=\"auto, (max-width: 1920px) 100vw, 1920px\" \/><\/p>\n<p>We are sincerely grateful to our partners \u2014 Members of Parliament, the Ministry of Health of Ukraine, the State Expert Center, and the State Service on Medicines and Drugs Control \u2014 with whom we stand side by side to secure Ukraine\u2019s place in the international research landscape. Thank you for your openness to cooperation and joint work to create a supportive regulatory environment for the recovery and growth of clinical trials in Ukraine. Every legislative update that removes barriers to conducting trials in Ukraine, and every approved protocol, brings not only investment in science and the economy, but also someone\u2019s chance for recovery.<\/p>\n<p class=\"x_MsoNormal\">The Clinical Trials Subcommittee of the European Business Association thanks the entire community for your trust, professionalism, and resilience. We will keep moving forward \u2014 for the restoration of clinical trials, the advancement of innovation, and for those who are still waiting for treatment.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>For over three years, the clinical trials industry in Ukraine has been operating under extremely challenging conditions due to russia\u2019s full-scale war against Ukraine. Yet the resilience, professionalism, and dignity shown by everyone involved in this field are inspiring. Sponsors, contract research organizations, logistics providers \u2014 despite all existing threats \u2014 remain loyal to patients [&hellip;]<\/p>\n","protected":false},"author":33544,"featured_media":643713,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[15564,15563,15574],"tags":[],"class_list":["post-789495","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-lobbying-news-en","category-main-news-en","category-news-and-articles-from-association-en"],"_links":{"self":[{"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/posts\/789495","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/users\/33544"}],"replies":[{"embeddable":true,"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/comments?post=789495"}],"version-history":[{"count":0,"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/posts\/789495\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/media\/643713"}],"wp:attachment":[{"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/media?parent=789495"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/categories?post=789495"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/tags?post=789495"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}